Efficacy and continuability of 675 mg fremanezumab administration over 2 years

Shohei Yoshida(Kanazawa University), Masahiro Serizawa(Mallinckrodt (United States)), Noboru Imai(Shizuoka Red Cross Hospital), Takashi Konishi(Shizuoka Red Cross Hospital), Riéko Suzuki(Shizuoka Red Cross Hospital), Masato Keicho(Shizuoka Red Cross Hospital), Asami Moriya(Shizuoka Red Cross Hospital), Jun Kamimura(Shizuoka Red Cross Hospital), Nobuyasu Yagi(Shizuoka Red Cross Hospital)
The Journal of Headache and Pain
March 11, 2025
Cited by 5


Related Papers